Upper airway symptoms in coronavirus disease 2019 (COVID-19)
According to a very large case series from the Chinese Center for Disease Control and Prevention (72,314 cases, updated through February 11, 2020), more than 80% of COVID-19 cases presented mild symptoms [1]. [...]the standard for detection of SARS-CoV-2 are real-time reverse-transcriptase polymeras...
Gespeichert in:
| Veröffentlicht in: | American journal of otolaryngology 2020-05, Vol.41 (3), p.102474-102474, Article 102474 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 102474 |
|---|---|
| container_issue | 3 |
| container_start_page | 102474 |
| container_title | American journal of otolaryngology |
| container_volume | 41 |
| creator | Lovato, Andrea de Filippis, Cosimo Marioni, Gino |
| description | According to a very large case series from the Chinese Center for Disease Control and Prevention (72,314 cases, updated through February 11, 2020), more than 80% of COVID-19 cases presented mild symptoms [1]. [...]the standard for detection of SARS-CoV-2 are real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assays collected by nasal and oropharyngeal swabs, meaning that virus load in these sites should be high [7]. The American Academy of Otolaryngology - Head and Neck Surgery [21], the Confederation of European Otorhinolaryngology - Head & Neck Surgery [22], the British Association of Otorhinolaryngology [23], the French [24] and Italian [25] ENT societies have already published recommendations for the use of PPE during upper airways examinations, endoscopy, or during surgical interventions (e.g. tracheostomy).Declaration of competing interest and source of funding The authors have nothing to declare. |
| doi_str_mv | 10.1016/j.amjoto.2020.102474 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7128936</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0196070920301563</els_id><sourcerecordid>2425677300</sourcerecordid><originalsourceid>FETCH-LOGICAL-c491t-208e31d99c5baad7209526ccd78da2b1c08fd02679b6dde5109de97b53569da3</originalsourceid><addsrcrecordid>eNp9kVFP2zAUha1paJRu_2CaIu0FHtLZ10kcSwgJlW0gIfWlIN4sx77dHDVxsJOi_ntSFRjjgSdL9rnH95yPkK-MzhhlxY96ppva934GFHZXkInsA5mwnENasvLuI5lQJouUCioPyVGMNaWUZzz_RA45gCgzQSfk9KbrMCTahQe9TeK26XrfxMS1ifHBt3rjwhAT6yLqiAmMjsnxfHF7dZEyefKZHKz0OuKXp3NKlr9-LueX6fXi99X8_Do1mWR9CrREzqyUJq-0tgKozKEwxorSaqiYoeXKUiiErAprMWdUWpSiynleSKv5lJztbbuhatAabPug16oLrtFhq7x26v-X1v1Vf_xGCQal5MVocPxkEPz9gLFXjYsG12vdoh-iAl5KGEtlMEq_v5HWfgjtmE5BBnkhBB9bnJJsrzLBxxhw9bIMo2pHR9VqT0ft6Kg9nXHs2-sgL0PPOP4lxbHNjcOgonHYGrQuoOmV9e79Hx4B2HKgpQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2425677300</pqid></control><display><type>article</type><title>Upper airway symptoms in coronavirus disease 2019 (COVID-19)</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Lovato, Andrea ; de Filippis, Cosimo ; Marioni, Gino</creator><creatorcontrib>Lovato, Andrea ; de Filippis, Cosimo ; Marioni, Gino</creatorcontrib><description>According to a very large case series from the Chinese Center for Disease Control and Prevention (72,314 cases, updated through February 11, 2020), more than 80% of COVID-19 cases presented mild symptoms [1]. [...]the standard for detection of SARS-CoV-2 are real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assays collected by nasal and oropharyngeal swabs, meaning that virus load in these sites should be high [7]. The American Academy of Otolaryngology - Head and Neck Surgery [21], the Confederation of European Otorhinolaryngology - Head & Neck Surgery [22], the British Association of Otorhinolaryngology [23], the French [24] and Italian [25] ENT societies have already published recommendations for the use of PPE during upper airways examinations, endoscopy, or during surgical interventions (e.g. tracheostomy).Declaration of competing interest and source of funding The authors have nothing to declare.</description><identifier>ISSN: 0196-0709</identifier><identifier>EISSN: 1532-818X</identifier><identifier>DOI: 10.1016/j.amjoto.2020.102474</identifier><identifier>PMID: 32278470</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Communicable Disease Control ; Coronavirus Infections - diagnostic imaging ; Coronavirus Infections - epidemiology ; Coronaviruses ; COVID-19 ; Disease control ; Disease transmission ; Endoscopy ; Female ; Global Health ; Head and neck ; Humans ; Incidence ; Infections ; Intensive care ; Male ; Ostomy ; Otolaryngology ; Pandemics - prevention & control ; Pandemics - statistics & numerical data ; Personal protective equipment ; Pneumonia, Viral - diagnostic imaging ; Pneumonia, Viral - epidemiology ; Polymerase chain reaction ; Respiratory tract diseases ; Respiratory Tract Infections - diagnosis ; Respiratory Tract Infections - epidemiology ; Respiratory Tract Infections - virology ; Risk Assessment ; SARS Virus - pathogenicity ; Severe acute respiratory syndrome coronavirus 2 ; Signs and symptoms ; Surgery ; Tracheostomy ; Viral diseases ; Viruses</subject><ispartof>American journal of otolaryngology, 2020-05, Vol.41 (3), p.102474-102474, Article 102474</ispartof><rights>2020 Elsevier Inc.</rights><rights>2020. Elsevier Inc.</rights><rights>2020 Elsevier Inc. All rights reserved. 2020 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c491t-208e31d99c5baad7209526ccd78da2b1c08fd02679b6dde5109de97b53569da3</citedby><cites>FETCH-LOGICAL-c491t-208e31d99c5baad7209526ccd78da2b1c08fd02679b6dde5109de97b53569da3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.amjoto.2020.102474$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32278470$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lovato, Andrea</creatorcontrib><creatorcontrib>de Filippis, Cosimo</creatorcontrib><creatorcontrib>Marioni, Gino</creatorcontrib><title>Upper airway symptoms in coronavirus disease 2019 (COVID-19)</title><title>American journal of otolaryngology</title><addtitle>Am J Otolaryngol</addtitle><description>According to a very large case series from the Chinese Center for Disease Control and Prevention (72,314 cases, updated through February 11, 2020), more than 80% of COVID-19 cases presented mild symptoms [1]. [...]the standard for detection of SARS-CoV-2 are real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assays collected by nasal and oropharyngeal swabs, meaning that virus load in these sites should be high [7]. The American Academy of Otolaryngology - Head and Neck Surgery [21], the Confederation of European Otorhinolaryngology - Head & Neck Surgery [22], the British Association of Otorhinolaryngology [23], the French [24] and Italian [25] ENT societies have already published recommendations for the use of PPE during upper airways examinations, endoscopy, or during surgical interventions (e.g. tracheostomy).Declaration of competing interest and source of funding The authors have nothing to declare.</description><subject>Communicable Disease Control</subject><subject>Coronavirus Infections - diagnostic imaging</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Disease control</subject><subject>Disease transmission</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Global Health</subject><subject>Head and neck</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infections</subject><subject>Intensive care</subject><subject>Male</subject><subject>Ostomy</subject><subject>Otolaryngology</subject><subject>Pandemics - prevention & control</subject><subject>Pandemics - statistics & numerical data</subject><subject>Personal protective equipment</subject><subject>Pneumonia, Viral - diagnostic imaging</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Polymerase chain reaction</subject><subject>Respiratory tract diseases</subject><subject>Respiratory Tract Infections - diagnosis</subject><subject>Respiratory Tract Infections - epidemiology</subject><subject>Respiratory Tract Infections - virology</subject><subject>Risk Assessment</subject><subject>SARS Virus - pathogenicity</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Signs and symptoms</subject><subject>Surgery</subject><subject>Tracheostomy</subject><subject>Viral diseases</subject><subject>Viruses</subject><issn>0196-0709</issn><issn>1532-818X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVFP2zAUha1paJRu_2CaIu0FHtLZ10kcSwgJlW0gIfWlIN4sx77dHDVxsJOi_ntSFRjjgSdL9rnH95yPkK-MzhhlxY96ppva934GFHZXkInsA5mwnENasvLuI5lQJouUCioPyVGMNaWUZzz_RA45gCgzQSfk9KbrMCTahQe9TeK26XrfxMS1ifHBt3rjwhAT6yLqiAmMjsnxfHF7dZEyefKZHKz0OuKXp3NKlr9-LueX6fXi99X8_Do1mWR9CrREzqyUJq-0tgKozKEwxorSaqiYoeXKUiiErAprMWdUWpSiynleSKv5lJztbbuhatAabPug16oLrtFhq7x26v-X1v1Vf_xGCQal5MVocPxkEPz9gLFXjYsG12vdoh-iAl5KGEtlMEq_v5HWfgjtmE5BBnkhBB9bnJJsrzLBxxhw9bIMo2pHR9VqT0ft6Kg9nXHs2-sgL0PPOP4lxbHNjcOgonHYGrQuoOmV9e79Hx4B2HKgpQ</recordid><startdate>20200501</startdate><enddate>20200501</enddate><creator>Lovato, Andrea</creator><creator>de Filippis, Cosimo</creator><creator>Marioni, Gino</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200501</creationdate><title>Upper airway symptoms in coronavirus disease 2019 (COVID-19)</title><author>Lovato, Andrea ; de Filippis, Cosimo ; Marioni, Gino</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c491t-208e31d99c5baad7209526ccd78da2b1c08fd02679b6dde5109de97b53569da3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Communicable Disease Control</topic><topic>Coronavirus Infections - diagnostic imaging</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Disease control</topic><topic>Disease transmission</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Global Health</topic><topic>Head and neck</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infections</topic><topic>Intensive care</topic><topic>Male</topic><topic>Ostomy</topic><topic>Otolaryngology</topic><topic>Pandemics - prevention & control</topic><topic>Pandemics - statistics & numerical data</topic><topic>Personal protective equipment</topic><topic>Pneumonia, Viral - diagnostic imaging</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Polymerase chain reaction</topic><topic>Respiratory tract diseases</topic><topic>Respiratory Tract Infections - diagnosis</topic><topic>Respiratory Tract Infections - epidemiology</topic><topic>Respiratory Tract Infections - virology</topic><topic>Risk Assessment</topic><topic>SARS Virus - pathogenicity</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Signs and symptoms</topic><topic>Surgery</topic><topic>Tracheostomy</topic><topic>Viral diseases</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lovato, Andrea</creatorcontrib><creatorcontrib>de Filippis, Cosimo</creatorcontrib><creatorcontrib>Marioni, Gino</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of otolaryngology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lovato, Andrea</au><au>de Filippis, Cosimo</au><au>Marioni, Gino</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Upper airway symptoms in coronavirus disease 2019 (COVID-19)</atitle><jtitle>American journal of otolaryngology</jtitle><addtitle>Am J Otolaryngol</addtitle><date>2020-05-01</date><risdate>2020</risdate><volume>41</volume><issue>3</issue><spage>102474</spage><epage>102474</epage><pages>102474-102474</pages><artnum>102474</artnum><issn>0196-0709</issn><eissn>1532-818X</eissn><abstract>According to a very large case series from the Chinese Center for Disease Control and Prevention (72,314 cases, updated through February 11, 2020), more than 80% of COVID-19 cases presented mild symptoms [1]. [...]the standard for detection of SARS-CoV-2 are real-time reverse-transcriptase polymerase-chain-reaction (RT-PCR) assays collected by nasal and oropharyngeal swabs, meaning that virus load in these sites should be high [7]. The American Academy of Otolaryngology - Head and Neck Surgery [21], the Confederation of European Otorhinolaryngology - Head & Neck Surgery [22], the British Association of Otorhinolaryngology [23], the French [24] and Italian [25] ENT societies have already published recommendations for the use of PPE during upper airways examinations, endoscopy, or during surgical interventions (e.g. tracheostomy).Declaration of competing interest and source of funding The authors have nothing to declare.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32278470</pmid><doi>10.1016/j.amjoto.2020.102474</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0196-0709 |
| ispartof | American journal of otolaryngology, 2020-05, Vol.41 (3), p.102474-102474, Article 102474 |
| issn | 0196-0709 1532-818X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7128936 |
| source | MEDLINE; Access via ScienceDirect (Elsevier) |
| subjects | Communicable Disease Control Coronavirus Infections - diagnostic imaging Coronavirus Infections - epidemiology Coronaviruses COVID-19 Disease control Disease transmission Endoscopy Female Global Health Head and neck Humans Incidence Infections Intensive care Male Ostomy Otolaryngology Pandemics - prevention & control Pandemics - statistics & numerical data Personal protective equipment Pneumonia, Viral - diagnostic imaging Pneumonia, Viral - epidemiology Polymerase chain reaction Respiratory tract diseases Respiratory Tract Infections - diagnosis Respiratory Tract Infections - epidemiology Respiratory Tract Infections - virology Risk Assessment SARS Virus - pathogenicity Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Surgery Tracheostomy Viral diseases Viruses |
| title | Upper airway symptoms in coronavirus disease 2019 (COVID-19) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T04%3A14%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Upper%20airway%20symptoms%20in%20coronavirus%20disease%202019%20(COVID-19)&rft.jtitle=American%20journal%20of%20otolaryngology&rft.au=Lovato,%20Andrea&rft.date=2020-05-01&rft.volume=41&rft.issue=3&rft.spage=102474&rft.epage=102474&rft.pages=102474-102474&rft.artnum=102474&rft.issn=0196-0709&rft.eissn=1532-818X&rft_id=info:doi/10.1016/j.amjoto.2020.102474&rft_dat=%3Cproquest_pubme%3E2425677300%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2425677300&rft_id=info:pmid/32278470&rft_els_id=S0196070920301563&rfr_iscdi=true |